Helen Susan Kim, EVP, Business Development at Kite Pharma, Inc. (KITE), sold 35,900 shares at $60.08 ($2.2M) on 2016-08-12, disclosed to the SEC on 2016-08-16.
Open-market sale of $2.2M KITE by EVP, Business Development. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $60.08 | 33,500 | $2.0M | 93.0% |
| 2 | $63.01 | 2,400 | $151K | 7.0% |
| Total | $60.27 avg | 35,900 | $2.2M | 100% |
| Filing → |
| AMTI | SELL | 2021-08-25 | $585K | — | Filing → |
| AMTI | SELL | 2021-07-06 | $17.3M | — | Filing → |
| KITE | SELL | 2017-09-27 | $1.1M | — | Filing → |